Newsletter
Join the Community
Subscribe to our newsletter for the latest news and updates
Generate professional appeal letters for mental health insurance denials backed by clinical evidence and federal law.
Traffic, search & AI signals for overturn.dev.
Third-party traffic estimate · Updated Aug 9, 2026
Submit your own product to reach creators and founders looking for the next tool to try.
Overturn is an AI-powered self-advocacy tool that generates professional appeal letters for mental health insurance denials, backed by PubMed clinical evidence and federal parity law.
Overturn is a specialized tool for appealing mental health insurance denials. Users upload their denial letter (PDF, photo, or text), and the AI extracts ICD-10 codes, CPT codes, denial reasons, and insurer policy language. It then searches PubMed for peer-reviewed studies and generates an appeal letter citing the Mental Health Parity and Addiction Equity Act (MHPAEA). The platform is web-based and offers a free case analysis; the full appeal letter costs $19.
Free case analysis; $19 for the full appeal letter. No subscriptions.
Under the ACA, you have 180 days from receiving the denial to file an internal appeal. Your insurer must respond within 30–60 days for standard appeals, or 72 hours for urgent ones. If denied, you can request an external review through your state's insurance commissioner.
All common behavioral health denials: therapy, substance use disorder, eating disorder, out-of-network, prior authorization, level-of-care disputes, medication step therapy, and more. It works with major insurers like Aetna, UnitedHealthcare, Blue Cross Blue Shield, Cigna, Humana, and Kaiser.
No. Overturn is a self-advocacy tool; it is not a law firm and does not provide legal representation. The letter cites real laws and evidence, but users should review it before submission.
Government data shows 39–59% of insurance appeals succeed overall; for medical necessity denials, about 83% are overturned when properly appealed with clinical evidence. Yet less than 1% of denied patients appeal.